Child Categories
Food & Drug Law
-
States’ Use Of Medicaid Managed Care ‘In Lieu Of Services’ Authority To Address Poor Nutrition
March 12, 2026
Kathryn Garfield, Erika Hanson, Carmel Shachar et al., States’ Use Of Medicaid Managed Care ‘In Lieu Of Services’ Authority To Address Poor Nutrition, 44 Health…
-
Essentials of Informed Consent to Psychedelic Medicine
March 12, 2026
Mason Marks, Rebecca W. Brendel, Carmel Shachar et al., Essentials of Informed Consent to Psychedelic Medicine, 81 JAMA Psychiatry 611 (2024).
-
Proposed Nutrition Competencies for Medical Students and Physician Trainees: A Consensus Statement
March 12, 2026
David M. Eisenberg, Alexis Cole, Edward J. Maile et al., Proposed Nutrition Competencies for Medical Students and Physician Trainees: A Consensus Statement, 7 JAMA Network…
-
The Time is Ripe: The Case for Nutrition in Graduate Medical Education in the United States
March 12, 2026
Bethany Agusala, Emily Broad Leib & Jaclyn Albin, The Time is Ripe: The Case for Nutrition in Graduate Medical Education in the United States, 11…
-
Carmel Shachar, Philip A. Gruppuso & Eli Y. Adashi, Pediatric Drug and Other Shortages in the Age of Supply Chain Disruption, 329 JAMA 2127 (2023).
-
Katharine Van Tassel, Carmel Shachar & Sharona Hoffman, Covid-19 Vaccine Injuries — Preventing Inequities in Compensation, New England J. Med. (2021).
-
Lessons from COVID-19 for behavioural and communication interventions to enhance vaccine uptake
March 6, 2026
Stephan Lewandowsky, Philipp Schmid, Katrine Bach Habersaat et al., Lessons from COVID-19 for behavioural and communication interventions to enhance vaccine uptake, 1 Commc’ns Psych. (2023).
-
Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement
March 6, 2026
Amy L. McGuire, I. Glenn Cohen, Dominic Sisti et al., Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement, 7 JAMA…
-
How Should the FDA Evaluate Psychedelic Medicine?
March 6, 2026
Mason Marks & I. Glenn Cohen, How Should the FDA Evaluate Psychedelic Medicine?, 389 New England J. Med. 1733 (2023).
-
Eli Y. Adashi, Daniel P. O’Mahony & I. Glenn Cohen, The FDA Modernization Act 2.0: Drug Testing in Animals is Rendered Optional, Am. J. Med.
-
Regulatory, Safety, and Privacy Concerns of Home Monitoring Technologies During COVID-19
March 6, 2026
Sara Gerke, Carmel Shachar, Peter R. Chai & I. Glenn Cohen, Regulatory, Safety, and Privacy Concerns of Home Monitoring Technologies During COVID-19, 26 Nature Med.
-
John H. Rex, Holly Fernandez Lynch, I. Glenn Cohen, Jonathan J. Darrow & Kevin Outterson, Designing Development Programs for Non-Traditional Antibacterial Agents, 10 Nature Comm.
-
Alyssa J. Moran, Emily Broad Leib & Christina A. Roberto, Science-Based Food Policies to Prevent Diet-Related Diseases (2025).
-
Checking in on Food Labeling: A Summary of Key Themes from Responses to USDA-FSIS and FDA’s Joint Request for Information
March 4, 2026
Akif Khan, Corinne Shanahan & Emily Broad Leib, Checking in on Food Labeling: A Summary of Key Themes from Responses to USDA-FSIS and FDA’s Joint…
-
Can Food Waste Policies Promote Sustainability?: Relationships of Food Date Label Policies with Food Waste and Safety Outcomes
March 4, 2026
Balca Alaybek, Grace Mika, John A. Aitken et al., Can Food Waste Policies Promote Sustainability?: Relationships of Food Date Label Policies with Food Waste and…
-
Supplemental Nutrition Assistance Program issuance timing is associated with sugar-sweetened beverage marketing in the USA
March 4, 2026
Jane Dai, Erica L. Kenney, Mark J. Soto et al., Supplemental Nutrition Assistance Program issuance timing is associated with sugar-sweetened beverage marketing in the USA,…
-
Stephen Devries & Emily Broad Leib, Nutrition education in medical training: it’s always been a matter of trust, 120 Am. J. Clinical Nutrition 465 (2024).
-
Ingesting Risk – The FDA and New Food Ingredients
March 4, 2026
Pieter A. Cohen & Emily M. Broad Leib, Ingesting Risk – The FDA and New Food Ingredients, 391 New England J. Med. 875 (2024).